The emerging role of SGLT2 inhibitors in the treatment of type 2 diabetes. Focus on dapagliflozin
- Type
- Retraction
- Notice date
- 4/5/2017 0:00
- Journal
- Romanian Journal of Diabetes, Nutrition and Metabolic Diseases
- Publisher
- De Gruyter
- Notice DOI
- 10.1515/rjdnmd-2017-0010
- Original paper DOI
- unavailable